vs

Side-by-side financial comparison of Figma, Inc. (FIG) and Privia Health Group, Inc. (PRVA). Click either name above to swap in a different company.

Privia Health Group, Inc. is the larger business by last-quarter revenue ($541.2M vs $274.2M, roughly 2.0× Figma, Inc.). Privia Health Group, Inc. runs the higher net margin — 1.7% vs -400.1%, a 401.8% gap on every dollar of revenue. On growth, Figma, Inc. posted the faster year-over-year revenue change (38.0% vs 17.4%).

Figma is a collaborative web application for interface design, with additional offline features enabled by desktop applications for macOS and Windows. The feature set of Figma focuses on user interface and user experience design, with an emphasis on real-time collaboration, utilizing a variety of vector graphics editor and prototyping tools. The Figma mobile app for Android and iOS allows viewing and interacting with Figma prototypes in real-time on mobile and tablet devices.

Privia Health Group, Inc. is a U.S.-headquartered healthcare technology and services firm supporting independent practices, health systems, and payers delivering value-based care. It offers population health tools, patient engagement platforms, care coordination support, and workflow solutions to boost patient outcomes and cut operational costs for U.S. healthcare stakeholders.

FIG vs PRVA — Head-to-Head

Bigger by revenue
PRVA
PRVA
2.0× larger
PRVA
$541.2M
$274.2M
FIG
Growing faster (revenue YoY)
FIG
FIG
+20.6% gap
FIG
38.0%
17.4%
PRVA
Higher net margin
PRVA
PRVA
401.8% more per $
PRVA
1.7%
-400.1%
FIG

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
FIG
FIG
PRVA
PRVA
Revenue
$274.2M
$541.2M
Net Profit
$-1.1B
$9.2M
Gross Margin
69.4%
Operating Margin
-414.6%
2.1%
Net Margin
-400.1%
1.7%
Revenue YoY
38.0%
17.4%
Net Profit YoY
-6933.0%
108.0%
EPS (diluted)
$-2.72
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FIG
FIG
PRVA
PRVA
Q4 25
$541.2M
Q3 25
$274.2M
$580.4M
Q2 25
$249.6M
$521.2M
Q1 25
$480.1M
Q4 24
$460.9M
Q3 24
$198.6M
$437.9M
Q2 24
$177.2M
$422.3M
Q1 24
$415.2M
Net Profit
FIG
FIG
PRVA
PRVA
Q4 25
$9.2M
Q3 25
$-1.1B
$6.9M
Q2 25
$28.2M
$2.7M
Q1 25
$4.2M
Q4 24
$4.4M
Q3 24
$-15.6M
$3.5M
Q2 24
$-827.9M
$3.5M
Q1 24
$3.0M
Gross Margin
FIG
FIG
PRVA
PRVA
Q4 25
Q3 25
69.4%
Q2 25
88.8%
Q1 25
Q4 24
Q3 24
90.6%
Q2 24
77.7%
Q1 24
Operating Margin
FIG
FIG
PRVA
PRVA
Q4 25
2.1%
Q3 25
-414.6%
2.5%
Q2 25
0.8%
0.6%
Q1 25
1.1%
Q4 24
1.1%
Q3 24
-23.8%
1.3%
Q2 24
-504.7%
1.2%
Q1 24
0.2%
Net Margin
FIG
FIG
PRVA
PRVA
Q4 25
1.7%
Q3 25
-400.1%
1.2%
Q2 25
11.3%
0.5%
Q1 25
0.9%
Q4 24
1.0%
Q3 24
-7.9%
0.8%
Q2 24
-467.2%
0.8%
Q1 24
0.7%
EPS (diluted)
FIG
FIG
PRVA
PRVA
Q4 25
$0.08
Q3 25
$-2.72
$0.05
Q2 25
$0.00
$0.02
Q1 25
$0.03
Q4 24
$0.03
Q3 24
$-0.07
$0.03
Q2 24
$-4.39
$0.03
Q1 24
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FIG
FIG
PRVA
PRVA
Cash + ST InvestmentsLiquidity on hand
$1.6B
$479.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$737.2M
Total Assets
$2.1B
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FIG
FIG
PRVA
PRVA
Q4 25
$479.7M
Q3 25
$1.6B
$441.4M
Q2 25
$1.6B
$390.1M
Q1 25
$469.3M
Q4 24
$491.1M
Q3 24
$416.1M
$422.0M
Q2 24
$586.1M
$387.4M
Q1 24
$351.1M
Stockholders' Equity
FIG
FIG
PRVA
PRVA
Q4 25
$737.2M
Q3 25
$1.4B
$709.1M
Q2 25
$1.4B
$682.9M
Q1 25
$659.4M
Q4 24
$635.2M
Q3 24
$1.2B
$614.9M
Q2 24
$862.4M
$595.4M
Q1 24
$576.8M
Total Assets
FIG
FIG
PRVA
PRVA
Q4 25
$1.4B
Q3 25
$2.1B
$1.4B
Q2 25
$2.0B
$1.3B
Q1 25
$1.2B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
Q1 24
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FIG
FIG
PRVA
PRVA
Operating Cash FlowLast quarter
$51.2M
$127.5M
Free Cash FlowOCF − Capex
$49.5M
FCF MarginFCF / Revenue
18.0%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
13.93×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FIG
FIG
PRVA
PRVA
Q4 25
$127.5M
Q3 25
$51.2M
$52.0M
Q2 25
$8.0M
Q1 25
$-24.1M
Q4 24
$74.8M
Q3 24
$33.2M
Q2 24
$34.5M
Q1 24
$-33.1M
Free Cash Flow
FIG
FIG
PRVA
PRVA
Q4 25
Q3 25
$49.5M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
FIG
FIG
PRVA
PRVA
Q4 25
Q3 25
18.0%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
FIG
FIG
PRVA
PRVA
Q4 25
Q3 25
0.6%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
FIG
FIG
PRVA
PRVA
Q4 25
13.93×
Q3 25
7.58×
Q2 25
2.97×
Q1 25
-5.70×
Q4 24
17.00×
Q3 24
9.38×
Q2 24
9.94×
Q1 24
-11.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FIG
FIG

Non Us$147.4M54%
US$126.8M46%

PRVA
PRVA

FFS Patient Care$364.4M67%
Capitated Revenue$71.4M13%
Shared Savings$46.9M9%
FFS Administrative Services$36.0M7%
Care Management Fee PMPM$20.0M4%
Other Revenue$2.5M0%

Related Comparisons